David Ledbetter
About David Ledbetter
David Ledbetter Education and Expertise
David Ledbetter is a graduate of Tulane University and earned his Ph.D. at the University of Texas-Austin. He is board certified by the American Board of Medical Genetics and Genomics as a clinical genetics laboratory director. With extensive experience in clinical genetics and genomics, Ledbetter has built substantial genetics diagnostics programs at prominent institutions, including Baylor College of Medicine, the University of Chicago, and Emory University School of Medicine.
David Ledbetter Professional Background
David Ledbetter has had a notable career in genetics and genomics, including serving as the Executive Vice President and Founding Chief Scientific Officer at Geisinger for 10 years. At Geisinger, he played a crucial role in advancing their MyCode biobank/genomics project. Currently, Ledbetter is the Chief Clinical & Research Officer at Unified Patient Network, Inc., a start-up focused on creating a vast Precision Medicine database.
David Ledbetter Genetic Research Contributions
Internationally recognized for his research on the genetic basis of childhood neurodevelopmental disorders, David Ledbetter discovered the genetic cause of Prader-Willi syndrome in 1981 and Miller-Dieker syndrome in 1983. His work has significantly contributed to the understanding and early diagnosis of these conditions, as well as translating new genomics technologies into clinically useful tests for autism and related disorders.
David Ledbetter Achievements in Genomics
David Ledbetter has made numerous contributions to the field of genomics, particularly in the realm of translating new technologies into clinical applications. His achievements include developing genetic tests for early diagnosis and intervention in autism and similar disorders, and his current research focuses on leveraging electronic health data with DNA sequencing to evaluate the clinical utility and cost-effectiveness of precision medicine.